
Global Clinical Trial Management Systems Market Size, Share, Growth Report, Industry Analysis, Trends and Forecast 2022-2027
According to the latest report by IMARC Group, titled "Global Clinical Trial Management Systems Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027", the global clinical trial management systems market reached a value of US$ 927.4 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,840.40 Million by 2027 exhibiting a CAGR of 11.50% during 2022-2027.
A clinical
trial management system (CTMS) is the software system that is used to plan,
track, and manage clinical trials in medical research studies. It includes a
suite of tools that manage the data generated through clinical trials conducted
by pharmaceutical companies and clinical research organizations. CTMS software
consists of start-up timelines, monitoring and reporting protocol information
and accrual data, financial management and billing compliance, and reporting
and business analytics. It also monitors and maintains contact information, and
tracks deadlines and milestones of participants.
Report
Metric |
Historical:
2016-2021 |
Base Year:
2021 |
Forecast
Year: 2022-2027 |
Clinical
Trial Management Systems Market Trends and Drivers:
The global
clinical trial management systems market is primarily driven by the growing
prevalence of chronic diseases coupled with the increasing number of clinical
trials undertaken by organizations.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/clinical-trial-management-systems-market/requestsample
As a result,
medical researchers are increasingly relying on CTMS software to access
transparent and unified critical components of study management and facilitate
the transfer of patient data. In addition to this, CTMS provides effective
patient safety and regulatory compliance, and enhanced financial management
capabilities, which is propelling the market growth.
Furthermore,
governments in various countries, and pharmaceutical and biopharmaceutical
companies are extensively investing in research and development (R&D)
activities, which is expected to positively influence the market growth in the
upcoming years.
Note: We are
regularly tracking the direct effect of COVID-19 on the market, along with the
indirect influence of associated industries. These observations will be
integrated into the report.
Global Clinical
Trial Management Systems Market 2022-2027 Analysis and Segmentation:
Competitive
Landscape:
The
competitive landscape of the market has been studied in the report with the
detailed profiles of the key players operating in the market.
Advarra
Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS
Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines
Corporation, Medidata Solutions Inc. (Dassault Systèmes SE), MedNet Solutions
Inc., Oracle Corporation, Parexel International Corporation, RealTime Software
Solutions LLC and Veeva Systems Inc.
The report
has segmented the market on the basis of region, component, deployment mode and
end user.
Breakup by
Component:
· Software
· Services
Breakup by
Deployment Mode:
· On-premises
· Cloud-based
Breakup by End User:
· Pharmaceuticals
· Contract
Research Organization
· Others
Breakup by
Region:
- North America: (United States,
Canada)
- Asia Pacific: (China,
Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United
Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico,
Others)
- Middle East and Africa
Ask Analyst
for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/clinical-trial-management-systems-market
If you want
latest primary and secondary data (2022-2027) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours of receiving full payment.
Key
highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success
Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the
Competitive Landscape
If you need
specific information that is not currently within the scope of the report, we
can provide it to you as a part of the customization.
About Us:
IMARC Group
is a leading market research company that offers management strategy and market
research worldwide. We partner with clients in all sectors and regions to
identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high
technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800